홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.3
  1. 홈
  2. /반응

Hydrochloric Acid → (6R,7R)-7-[[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-3-[(2-methyl-5,6-dioxo-1H-1,2,4-triazin-3-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid;(2S)-2,6-diaminohexanoic acid

HRID 1067164
인쇄

반응식

HRID 1067164 반응식
[NH2:1][C@H:2]([C:8]([OH:10])=[O:9])[CH2:3][CH2:4][CH2:5][CH2:6][NH2:7].[CH3:11][N:12]1[N:18]=[C:17]([OH:19])[C:15](=[O:16])[N:14]=[C:13]1[S:20][CH2:21][C:22]1[CH2:43][S:42][C@@H:25]2[C@H:26]([NH:29][C:30](/[C:32](/[C:36]3[N:40]=[C:39]([NH2:41])[S:38][CH:37]=3)=[N:33]\[O:34][CH3:35])=[O:31])[C:27](=[O:28])[N:24]2[C:23]=1[C:44]([OH:46])=[O:45].N[C@H](C(O)=O)CCCNC(=N)N.Cl>O>[CH3:11][N:12]1[N:18]=[C:17]([OH:19])[C:15](=[O:16])[N:14]=[C:13]1[S:20][CH2:21][C:22]1[CH2:43][S:42][C@@H:25]2[C@H:26]([NH:29][C:30](/[C:32](/[C:36]3[N:40]=[C:39]([NH2:41])[S:38][CH:37]=3)=[N:33]\[O:34][CH3:35])=[O:31])[C:27](=[O:28])[N:24]2[C:23]=1[C:44]([OH:46])=[O:45].[NH2:1][C@H:2]([C:8]([OH:10])=[O:9])[CH2:3][CH2:4][CH2:5][CH2:6][NH2:7]
참가 물질실험 절차출처 및 근거반응 노트

참가 물질

6

반응물 4

HCID 313Hydrochloric AcidHCID 5962L-Lysine2회HCID 178418600HCID 178418600, 화합물HCID 178502822HCID 178502822, 화합물2회

생성물 1

HCID 178502824(6R,7R)-7-[[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-3-[(2-methyl-5,6-dioxo-1H-1,2,4-triazin-3-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid;(2S)-2,6-diaminohexanoic acid

시약·촉매·용매 1

HCID 962Water용매2회

실험 절차

About 610 mg (3.34 mole) of particulate lysine was dissolved in 50 ml of distilled water. Additionally, 1.0 gram (1.67 mole) of ceftriaxone was dissolved in 50 ml of a separate volume of distilled water. The solution containing arginine was adjusted with 1N-HCl until the solution reached pH 6.0. The ceftriaxone solution was then added to the lysine solution and stirred by a magnetic stirrer at room temperature for 1 hour forming a ceftriaxone-lysine solution. To the ceftriaxone-lysine solution was added about 400 mg of carrageenan and the solution was stirred by magnetic stirrer at room temperature for 2 hours. A ceftriaxone-lysine-carrageenan hydrogel was formed. The hydrogel was then freeze-dried while in the swollen state, yielding about 1.92 g of the freeze dried complex.

출처 및 근거

ORD 기록
ord-f7b075e1a5884dfdb4b372d3702a1048
출처 데이터셋
uspto-grants-2001_06
DOI
10.6084/m9.figshare.5104873.v1
특허 번호
US06248360B1

반응 노트

이 페이지에서참가 물질실험 절차출처 및 근거반응 노트